153 related articles for article (PubMed ID: 30424894)
1. External validation of a prognostic model incorporating quantitative PET image features in oesophageal cancer.
Foley KG; Shi Z; Whybra P; Kalendralis P; Larue R; Berbee M; Sosef MN; Parkinson C; Staffurth J; Crosby TDL; Roberts SA; Dekker A; Wee L; Spezi E
Radiother Oncol; 2019 Apr; 133():205-212. PubMed ID: 30424894
[TBL] [Abstract][Full Text] [Related]
2. Prediction of lymph node metastases using pre-treatment PET radiomics of the primary tumour in esophageal adenocarcinoma: an external validation study.
Zhang C; Shi Z; Kalendralis P; Whybra P; Parkinson C; Berbee M; Spezi E; Roberts A; Christian A; Lewis W; Crosby T; Dekker A; Wee L; Foley KG
Br J Radiol; 2021 Feb; 94(1118):20201042. PubMed ID: 33264032
[TBL] [Abstract][Full Text] [Related]
3. Additional value of EUS in oesophageal cancer patients staged N0 on PET/CT: validation of a prognostic model.
Foley KG; Fielding P; Lewis WG; Roberts SA
Surg Endosc; 2018 Dec; 32(12):4973-4979. PubMed ID: 29869086
[TBL] [Abstract][Full Text] [Related]
4. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy.
Xie C; Yang P; Zhang X; Xu L; Wang X; Li X; Zhang L; Xie R; Yang L; Jing Z; Zhang H; Ding L; Kuang Y; Niu T; Wu S
EBioMedicine; 2019 Jun; 44():289-297. PubMed ID: 31129097
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging
Beukinga RJ; Hulshoff JB; Mul VEM; Noordzij W; Kats-Ugurlu G; Slart RHJA; Plukker JTM
Radiology; 2018 Jun; 287(3):983-992. PubMed ID: 29533721
[TBL] [Abstract][Full Text] [Related]
6. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer.
Foley KG; Hills RK; Berthon B; Marshall C; Parkinson C; Lewis WG; Crosby TDL; Spezi E; Roberts SA
Eur Radiol; 2018 Jan; 28(1):428-436. PubMed ID: 28770406
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.
Duong CP; Hicks RJ; Weih L; Drummond E; Leong T; Michael M; Thomas RJ
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):770-8. PubMed ID: 16550384
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.
Metzger JC; Wollschläger D; Miederer M; Vaupel P; Moehler M; Schmidberger H; Mayer A
Strahlenther Onkol; 2017 Oct; 193(10):791-799. PubMed ID: 28770295
[TBL] [Abstract][Full Text] [Related]
12. Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery.
Shapiro J; van Klaveren D; Lagarde SM; Toxopeus EL; van der Gaast A; Hulshof MC; Wijnhoven BP; van Berge Henegouwen MI; Steyerberg EW; van Lanschot JJ
Br J Surg; 2016 Jul; 103(8):1039-47. PubMed ID: 27115731
[TBL] [Abstract][Full Text] [Related]
13. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683
[TBL] [Abstract][Full Text] [Related]
15. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ
J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.
Goense L; Merrell KW; Arnett AL; Hallemeier CL; Meijer GJ; Ruurda JP; Hofstetter WL; van Hillegersberg R; Lin SH
Ann Thorac Surg; 2018 Nov; 106(5):1541-1547. PubMed ID: 29932887
[TBL] [Abstract][Full Text] [Related]
19. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.
Duong CP; Demitriou H; Weih L; Thompson A; Williams D; Thomas RJ; Hicks RJ
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):759-69. PubMed ID: 16470369
[TBL] [Abstract][Full Text] [Related]
20. Textural features based enhanced contrast CT images predicts prognosis to concurrent chemoradiotherapy in stage III esophageal squamous cell cancer.
Xie Y; Wang Q; Cao B; Lv J; Wang Y; Wu L; Dong M; Li T
Cancer Biomark; 2020; 27(3):325-333. PubMed ID: 31903981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
